Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-17
2006-10-17
O'Sullivan, Peter (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S211090, C514S230500, C540S468000, C540S552000, C544S105000
Reexamination Certificate
active
07122536
ABSTRACT:
The invention relates to substituted aryl and heteroaryl (R)-Chiral Halogenated 1-Substitutedamino-(n+1)-Alkanol compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Novel high yield, stereoselective processes for the preparation of the chiral substituted alkanol compounds from chiral and achiral intermediates are described.
REFERENCES:
patent: 2700686 (1955-01-01), Dickey et al.
patent: 3334017 (1967-08-01), Biel
patent: 3359316 (1967-12-01), Biel
patent: 3534100 (1970-10-01), Bollag et al.
patent: 5306718 (1994-04-01), Lauffer et al.
patent: 5932587 (1999-08-01), Schmeck et al.
patent: 6063788 (2000-05-01), Brandes et al.
patent: 6069148 (2000-05-01), Schmidt et al.
patent: 6127383 (2000-10-01), Schmidt et al.
patent: 6448295 (2002-09-01), Sikorski et al.
patent: 6451823 (2002-09-01), Sikorski et al.
patent: 6451830 (2002-09-01), Sikorski et al.
patent: 6455519 (2002-09-01), Sikorski et al.
patent: 6458803 (2002-10-01), Sikorski et al.
patent: 6458852 (2002-10-01), Sikorski et al.
patent: 6462092 (2002-10-01), Sikorski et al.
patent: 6476057 (2002-11-01), Sikorski et al.
patent: 6476075 (2002-11-01), Sikorski et al.
patent: 6479552 (2002-11-01), Sikorski et al.
patent: 6482862 (2002-11-01), Sikorski et al.
patent: 6521607 (2003-02-01), Sikorski et al.
patent: 6544974 (2003-04-01), Sikorski et al.
patent: 6583183 (2003-06-01), Sikorski et al.
patent: 6586433 (2003-07-01), Sikorski et al.
patent: 6605624 (2003-08-01), Lee et al.
patent: 6677341 (2004-01-01), Sikorski et al.
patent: 6677353 (2004-01-01), Sikorski et al.
patent: 6677375 (2004-01-01), Sikorski et al.
patent: 6677379 (2004-01-01), Sikorski et al.
patent: 6677380 (2004-01-01), Sikorski et al.
patent: 6677382 (2004-01-01), Sikorski et al.
patent: 6683099 (2004-01-01), Sikorski et al.
patent: 6683113 (2004-01-01), Sikorski et al.
patent: 6696435 (2004-02-01), Sikorski et al.
patent: 6696472 (2004-02-01), Sikorski et al.
patent: 6699898 (2004-03-01), Sikorski et al.
patent: 6710089 (2004-03-01), Sikorski et al.
patent: 6723752 (2004-04-01), Sikorski et al.
patent: 6723753 (2004-04-01), Sikorski et al.
patent: 6765023 (2004-07-01), Sikorski et al.
patent: 6787570 (2004-09-01), Sikorski et al.
patent: 6794396 (2004-09-01), Sikorski et al.
patent: 6803388 (2004-10-01), Sikorski et al.
patent: 441366 (1968-01-01), None
patent: 19627430 (1998-01-01), None
patent: 0442172 (1991-08-01), None
patent: 0314435 (1993-09-01), None
patent: 0801060 (1997-10-01), None
patent: 0796846 (2000-07-01), None
patent: 0818197 (2003-11-01), None
patent: 0818448 (2003-11-01), None
patent: 2305665 (1997-04-01), None
patent: 5320117 (1993-12-01), None
patent: 10287662 (1998-10-01), None
patent: WO9001874 (1990-03-01), None
patent: WO9002113 (1990-03-01), None
patent: WO9738973 (1997-10-01), None
patent: WO9839299 (1998-09-01), None
Barter, P. J., et al.High density lipoproteins and coronary heart disease, Atherosclerosis, vol. 121, pp. 1-12 (1996).
Tall, A. R.,Plasma cholesteryl ester transfer protein, Journal of Lipid Research, vol. 34, pp. 1255-1274 (1993).
McCarthy, P. A., et al.,New Approaches to Atherosclerosis: An Overview, Medicinal Research Reviews, vol. 13, No. 2, pp. 139-159, (1993).
Sirtori, C. R.,New Targets for Lipid Lowering and Atherosclerosis Prevention, Pharmac. Ther., vol. 67, No. 3, pp. 433-447 (1995).
Swenson, T. L., et al.,Mechanism of Cholesteryl Ester Transfer Protein Inhibition by a Neutralizing Monoclonal Antibody and Mapping of the Monoclonal Antibody Epitope, Journal of Biological Chemistry, vol. 264, No. 24, pp. 14318-14326, (1989).
Son, Y. C., et a.,Purification and Characterization of Human Plasma Proteins that Inhibit Lipid Transfer Activities, Biochimica et Biophysica Acta, vol. 795, pp. 473-480, (1984).
Morton, R. E., et al.,Regulation of lipid transfer between lipoproteins by an endogenous plasma protein: selective inhibition among lipoprotein classes, Journal of Lipid Research, vol. 35, pp. 836-847, (1994).
Tollefson, J. H., et al.,Regulation of plasma lipid transfer by the high-density lipoproteins, American Physiological Society, pp. E894-E902, (1988).
Cho, Kyung-Hyun, et al.,A peptide from hog plasma that inhibits human cholesteryl ester transfer protein, Biochimica et Biophysica Acta, vol. 1391, pp. 133-144 (1998).
Hegde, V. R., et al.A depsipeptide fungal metabolite inhibitor of cholesteryl ester transfer protein, Biorganic&Medicinal Chemistry Letters, vol. 8, pp. 1277-1280, (1998).
Barrett, A. G. M., et al.,Total Synthesis and Stereochemical Assignment of the Quinquecyclopropane-Containing Cholesteryl Ester Transfer Protein Inhibitor U-106305, J. Am. Chem. Soc., vol. 118, pp. 7863-7864 (1996).
Kuo, M. S., et al.,Discovery, Isolation, Structure Elucidation, and Biosynthesis of U-106305, a Cholesteryl Ester Transfer Protein Inhibitor from UC 11136, J. Am. Chem. Soc., vol. 117, pp. 10629-10634, (1995).
Pietzonka, T., et al.,Phosphonate-containing Analogs of Cholesteryl Ester as Novel Inhibitors of Cholesteryl Ester Transfer Protein, Bioorganic&Medicinal Chemistry Letters, vol. 6, No. 16, pp. 1951-9154 (1996).
Coval, S. J., et al.,Wiedendiol-A and -B Cholesteryl Ester Transfer Protein Inhibitors from the Marin Sponge Xestospongia Wiedenmayeri, Bioorganic&Medicinal Chemistry Letters, vol. 5, No. 6, pp. 605-610 (1995).
Lee, J. C., et al.,A Cholesteryl Ester Transfer Protein Inhibitor from an Insect-associated Fungus, The Journal of Antibiotics, vol. 49, No. 7, pp. 693-696, (1996).
Busch, S. J., et al.,Cholesteryl Ester Analogs Inhibit Cholesteryl Ester but not Triglyceride Transfer Catalyzed by the Plasma Cholesteryl Ester-Triglyceride Transfer Protein, Lipids, vol. 25, No. 4, pp. 216-220 (1990).
Connolly, D. T., et al.,Inactivation of Cholesteryl Ester Transfer Protein by Cysteine Modification, Biochemical&Biophysical Research Communications, vol. 223, pp. 42-47 (1996).
Xia, Y., et al.,Substituted 1,3,5-Triazines as Cholesteryl Ester Transfer Protein Inhibitors, Bioorganic&Medicinal Chemistry Letters, vol. 6, No. 7, pp. 919-922 (1996).
Bisgaier, C. L., et al.;Cholesteryl Ester Transfer Protein Inhibition by PD 140195, Lipids, vol. 29, No. 12, pp. 811-818, (1994).
Wagaw, S., et al.,The Synthesis of Aminopyridines: A Method Employing Palladium-Catalyzed Carbon-Nitrogen Bond Formation, J. Org. Chem., vol. 61, pp. 7240-7241, (1996).
Wolfe, J. P., et al.,An Improved Catalyst System for Aromatic Carbon-Nitrogen Bond Formation: The Possible Involvement of Bis(Phosphine) Palladium Complexes as Key Intermediates, J. Am. Chem. Soc., vol. 118, pp. 7215-7216, (1996).
Wolfe, J. P., et al.,Improved Functional Group Compatibility in the Palladium-Catalyzed Amination of Aryl Bromides, Tetrahedron Letters, vol. 38, No. 36, pp. 6359-6362 (1997).
Marcoux, J. F., et al.A General Copper-Catalyzed Synthesis of Diaryl Ethers, J. Am. Chem. Soc., vol. 119, pp. 10539-10540, (1997).
Sheradsky, T., et al.,Studies on the Preparation of N-Alkyl-O-phenylhydroxylamines, J. Chem. Soc. Perkin Trans., vol. 12, pp. 2781-2781, (1980).
Stembach, D. D., et al.Reduction of O-Acyl Oximes, Tetrahedron Letters, vol. 22, No. 35, pp. 3331-3334, (1981).
Ramachandran, P. V., et al.,Chiral Synthesis via Organoboranes. 40. Selective Reductions. 55. A Simple One-Pot Synthesis of the Enantiomers of (Trifluoromethyl)oxirane. A General Synthesis in High Optical Purities of α-Trifluoromethyl Secondary Alcohols via the Ring-Cleavage Reactions of the Epoxide, J. Org. Chem., vol. 60, pp. 41-46, (1995).
McBee, E. T., et al.,The Preparation and Properties of 3,3,3-Trifluoro-1,2-epoxypropane, J. Am. Chem. Soc., vol. 74, pp. 3022-3023 (1952).
DesMarteau, D. D., et al.,The first fluoroalkylation of amino acids and peptides in water utilizing the novel iodonium salt (CF3SO2)2NI(Ph)CH2CF3,Chem. Commun., pp. 2241-2242 (1998).
Reagents for Organic Synthesis, Feiser & Feiser, vol. 1, copyright 1967, John Wiley & Sons, Inc.
Vogel's Textbook of Practical Organic Chemistry, Fift
Durley Richard C.
Fobian Yvette M.
Grapperhaus Margaret L.
Hamme Ashton T.
Hickory Brian S.
Benson Gregg C.
O'Sullivan Peter
Pfizer Inc.
Samuels Lisa A.
LandOfFree
(R)-chiral halogenated substituted fused heterocyclic amino... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (R)-chiral halogenated substituted fused heterocyclic amino..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (R)-chiral halogenated substituted fused heterocyclic amino... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3664305